Is rapamycin the next big breakthrough in periodontitis and oral cancer treatment?

  Originally developed as an immunosuppressant, rapamycin is now being studied for its wide-ranging potential in oral health—particularly in treating periodontitis, oral dysbiosis, and oral cancer. Anne O. Rice, BS, RDH, CDP, FAAOSH   Read by Jackie Sanders Link: https://www.rdhmag.com/pathology/oral-systemic/article/55237017/is-rapamycin-the-next-big-breakthrough-in-periodontitis-and-oral-cancer-treatment